| Pleiotropic effects of statins: A focus on cancer M Ahmadi, S Amiri, S Pecic, F Machaj, J Rosik, MJ Łos, J Alizadeh, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (12), 165968, 2020 | 179 | 2020 |
| Recognition and sensing of low-epitope targets via ternary complexes with oligonucleotides and synthetic receptors KA Yang, M Barbu, M Halim, P Pallavi, B Kim, DM Kolpashchikov, S Pecic, ... Nature chemistry 6 (11), 1003-1008, 2014 | 155 | 2014 |
| High-affinity nucleic-acid-based receptors for steroids KA Yang, H Chun, Y Zhang, S Pecic, N Nakatsuka, AM Andrews, ... ACS chemical biology 12 (12), 3103-3112, 2017 | 131 | 2017 |
| Enhancing autophagy in Alzheimer's disease through drug repositioning M Eshraghi, M Ahmadi, S Afshar, S Lorzadeh, A Adlimoghaddam, ... Pharmacology & therapeutics 237, 108171, 2022 | 96 | 2022 |
| Discovery of new classes of compounds that reactivate acetylcholinesterase inhibited by organophosphates FS Katz, S Pecic, TH Tran, I Trakht, L Schneider, Z Zhu, L Ton‐That, ... ChemBioChem 16 (15), 2205-2215, 2015 | 92 | 2015 |
| Ceramides and ceramide synthases in cancer: Focus on apoptosis and autophagy J Alizadeh, SC da Silva Rosa, X Weng, J Jacobs, S Lorzadeh, A Ravandi, ... European Journal of Cell Biology 102 (3), 151337, 2023 | 89 | 2023 |
| Rhabdomyosarcoma: current therapy, challenges, and future approaches to treatment strategies A Zarrabi, D Perrin, M Kavoosi, M Sommer, S Sezen, P Mehrbod, ... Cancers 15 (21), 5269, 2023 | 74 | 2023 |
| Synthesis, kinetic evaluation and molecular docking studies of donepezil-based acetylcholinesterase inhibitors M Makarian, M Gonzalez, SM Salvador, S Lorzadeh, PK Hudson, S Pecic Journal of Molecular Structure 1247, 131425, 2022 | 60 | 2022 |
| Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies S Pecic, P Makkar, S Chaudhary, BV Reddy, HA Navarro, WW Harding Bioorganic & medicinal chemistry 18 (15), 5562-5575, 2010 | 44 | 2010 |
| Structure-switching aptamer sensors for the specific detection of piperaquine and mefloquine ES Coonahan, KA Yang, S Pecic, M De Vos, TE Wellems, MP Fay, ... Science Translational Medicine 13 (585), eabe1535, 2021 | 41 | 2021 |
| Synthesis and structure–activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors S Pecic, S Pakhomova, ME Newcomer, C Morisseau, BD Hammock, ... Bioorganic & medicinal chemistry letters 23 (2), 417-421, 2013 | 40 | 2013 |
| Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase S Pecic, SX Deng, C Morisseau, BD Hammock, DW Landry Bioorganic & medicinal chemistry letters 22 (1), 601-605, 2012 | 38 | 2012 |
| Microwave-assisted direct biaryl coupling: first application to the synthesis of aporphines S Chaudhary, S Pecic, O LeGendre, WW Harding Tetrahedron letters 50 (20), 2437-2439, 2009 | 38 | 2009 |
| Reinvestigating old pharmacophores: are 4-aminoquinolines and tetraoxanes potential two-stage antimalarials? N Terzic, J Konstantinovic, M Tot, J Burojevic, O Djurkovic-Djakovic, ... Journal of Medicinal Chemistry 59 (1), 264-281, 2016 | 37 | 2016 |
| Nanoparticles: The future of effective diagnosis and treatment of colorectal cancer? R Naeimi, R Najafi, P Molaei, R Amini, S Pecic European journal of pharmacology 936, 175350, 2022 | 32 | 2022 |
| Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability S Pecic, AA Zeki, X Xu, GY Jin, S Zhang, S Kodani, M Halim, C Morisseau, ... Prostaglandins & other lipid mediators 136, 90-95, 2018 | 30 | 2018 |
| (±)-Nantenine analogs as antagonists at human 5-HT2A receptors: C1 and flexible congeners S Chaudhary, S Pecic, O LeGendre, HA Navarro, WW Harding Bioorganic & medicinal chemistry letters 19 (9), 2530-2532, 2009 | 30 | 2009 |
| Nantenine as an acetylcholinesterase inhibitor: SAR, enzyme kinetics and molecular modeling investigations S Pecic, MA McAnuff, WW Harding Journal of enzyme inhibition and medicinal chemistry 26 (1), 46-55, 2011 | 29 | 2011 |
| Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors S Wilt, S Kodani, L Valencia, PK Hudson, S Sanchez, T Quintana, ... Bioorganic & medicinal chemistry 51, 116507, 2021 | 27 | 2021 |
| Development of multitarget inhibitors for the treatment of pain: Design, synthesis, biological evaluation and molecular modeling studies S Wilt, S Kodani, TNH Le, L Nguyen, N Vo, T Ly, M Rodriguez, PK Hudson, ... Bioorganic chemistry 103, 104165, 2020 | 26 | 2020 |
Bruce D. HammockUniversity of California DavisVerified email at ucdavis.edu
